Delivery Order SPE2DB22D3301-SPE2DB25FZ0FA
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets (60-count) with a ceiling value of $26,140.92. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $95,223.63 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, open-market award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order from the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Eliquis 2.5 mg tablets (60 count) with a contract value of $7,862.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract represents a single order fulfillment under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $5,382.14. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on July 28, 2025, for supply of Eliquis 5 mg tablets in quantities of 60-count packages. This competitively awarded, non-set-aside contract carries a ceiling value of $43,468.64 under firm fixed price terms, with an ultimate completion date of July 29, 2025. The place of performance is listed as the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,156.88 by the Defense Logistics Agency Medical Supply Chain on July 25, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $36,722.05. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,698.09 by the Defense Logistics Agency on July 31, 2025, for the supply of Eliquis 5 mg tablets (60-count). The award utilizes a firm fixed-price contract structure with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $27,225.53 on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $17,176.10 delivery order from the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, competitively awarded contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0FADelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 28, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $7,462.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and represents fulfillment under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The underlying IDC, valued at $999.99 million through December 2026, serves as a comprehensive pharmaceutical supply vehicle designated SPE2DX, enabling AmerisourceBergen to distribute a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains a significant portfolio of delivery orders through the DLA Medical Supply Chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Eliquis, an anticoagulant medication, aligns with the company's demonstrated capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains. No set-aside designation was applied to this award, reflecting AmerisourceBergen's competitive standing in the open federal procurement market for pharmaceutical products and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 8/28/25 |